Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration

Keele and Stirling, UK – Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising in the sterile manufacture of injectable viral vector drug products, today announced the successful completion of their collaboration to develop synergistic and world leading capabilities.Intended to accelerate the clinical… Read More

Symbiosis boosts business development team to support US growth

Stirling, UK – LEADING contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has boosted its business development team to support its growth and continued development in the US.Business development manager Helen Caddy-Leach will be responsible for maximising the CMO’s presence in the US market, working with new and existing clients to ensure the continued successful delivery of sterile biomanufacturing services to US clients.Symbiosis,… Read More

vial filling services

Freeline, Symbiosis and the Cell and Gene Therapy Catapult secure collaborative funding from Innovate UK

London, UK – Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, has secured a collaborative grant of £1.3 million from Innovate UK to lead a supply chain model and delivery development project in partnership with Symbiosis Pharmaceutical Services (Symbiosis) and the Cell and Gene Therapy Catapult (CGTC). The project is intended to create a UK based novel viral vector supply… Read More

Symbiosis secures FDA viral vector process approval

Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK.Symbiosis recently hosted a successful inspection by the United States Government Food and Drug Administration (FDA) for the aseptic manufacture of viral vector products for commercial supply into the U.S market… Read More

Cobra Biologics and Symbiosis awarded £1.9m ($2.5m USD) Innovate UK Grant

Keele and Stirling, UK, 1 February 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, today announced that they have been awarded a 16-month collaborative grant of £1.9m from Innovate UK.The grant will position the partner companies as globally recognised… Read More

Cover story: Scottish Specialty CMO Thrives as ‘One-Stop-Shop’ Becomes the Trend

We were recently invited to feature in Pharmaceutical Processing’s Apri/May edition with a cover story on how Symbiosis Pharmaceutical Services has thrived as a small-scale, niche sterile manufacturer depsite the ‘one-stop-shop’ model becoming the trend.Throughout the article, Colin Mackay outlines how our facility in Stirling, Scotland has addressed specific gaps in the sterile drug product manufacturing marketplace. He also addresses not only our… Read More

Roundtable: Aseptic Manufacturing Trends

CEO of Symbiosis Pharmaceutical Services, Colin Mackay, was recently invited to participate in a roundtable discussion on aseptic manufacturing trends for Contract Pharma along with leaders from Recipharm and ChargePoint Technology.The resulting article explores key trends and challenges when it comes to aseptic manufacturing.In the article, Colin explains: “The development of robust single-use manufacturing technology has been a step-change in the sector, enabling more efficient… Read More

Scottish CMO opens US office

Symbiosis Pharmaceutical Services is set to open an office in North America in response to continued demand from US-based biotechnology companies for its vial-filling expertise.The sterile filling specialist will open a commercial site in Cambridge, Boston, MA, to support its clients on both the East and West Coast, as well as giving the contract manufacturing organisation (CMO) a base for reaching new customers… Read More

Get In Touch